Related Experiment Video

Updated: Jun 25, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

miR-449a targets HDAC-1 and induces growth arrest in prostate cancer

E J Noonan1, R F Place, D Pookot

  • 1Department of Urology, Veterans Affairs Medical Center and University of California, San Francisco, CA 94121, USA. emily.noonan@gmail.com

Oncogene
|March 3, 2009
PubMed

Insights

MicroRNA-449a (miR-449a) is downregulated in prostate cancer, inhibiting cancer cell growth by targeting histone deacetylase 1 (HDAC-1). Restoring miR-449a induces apoptosis and cell-cycle arrest, offering new therapeutic insights.

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Cancer Research

Background:

  • Histone deacetylases (HDACs) are often overexpressed in cancers, promoting tumor growth and survival through epigenetic alterations.
  • The mechanisms driving HDAC overexpression in human cancers are not fully understood.
  • MicroRNAs (miRNAs) play crucial roles in gene regulation and are implicated in various diseases, including cancer.

Purpose of the Study:

  • To investigate the expression and function of miR-449a in prostate cancer.
  • To identify the molecular targets of miR-449a in prostate cancer cells.
  • To elucidate the role of miR-449a in regulating HDAC expression and its impact on prostate cancer biology.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) to assess miR-449a expression levels in prostate cancer tissues and cell lines.
  • Cell-based assays to evaluate the effects of miR-449a introduction on cell-cycle progression, apoptosis, and senescence.
  • Bioinformatic analysis of 3'-untranslated regions (3'-UTRs) to predict miR-449a targets.
  • Luciferase 3'-UTR reporter assays to validate direct interaction between miR-449a and its target genes, specifically HDAC-1.

Main Results:

  • miR-449a was found to be significantly downregulated in prostate cancer tissues compared to matched normal tissues.
  • Restoration of miR-449a in prostate cancer cells (PC-3) induced cell-cycle arrest, apoptosis, and a senescent phenotype.
  • Bioinformatic and luciferase assays confirmed histone deacetylase 1 (HDAC-1) as a direct target of miR-449a.
  • miR-449a was shown to regulate prostate cancer cell growth and viability by repressing HDAC-1 expression.

Conclusions:

  • miR-449a acts as a tumor suppressor in prostate cancer by targeting and downregulating HDAC-1.
  • The dysregulation of miR-449a contributes to the epigenetic alterations observed in prostate cancer.
  • These findings highlight the potential of targeting the miR-449a/HDAC-1 axis for prostate cancer therapy.

More Related Videos

Examination of Proteins Bound to Nascent DNA in Mammalian Cells Using BrdU-ChIP-Slot-Western Technique09:14

Examination of Proteins Bound to Nascent DNA in Mammalian Cells Using BrdU-ChIP-Slot-Western Technique

Published on: January 14, 2016

Assays for Validating Histone Acetyltransferase Inhibitors09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...